Paul Tudor Jones’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.5M Sell
53,100
-362,800
-87% -$84.6M 0.02% 671
2026
Q1
$102M Buy
415,900
+312,300
+301% +$72.7M 0.19% 81
2025
Q4
$21.4M Sell
103,600
-274,800
-73% -$54.3M 0.04% 392
2025
Q3
$70.2M Buy
378,400
+293,000
+343% +$50.2M 0.12% 114
2025
Q2
$13M Buy
85,400
+13,800
+19% +$2.12M 0.03% 533
2025
Q1
$11.9M Buy
71,600
+26,900
+60% +$4.21M 0.04% 394
2024
Q4
$6.46M Sell
44,700
-4,000
-8% -$620K 0.02% 563
2024
Q3
$7.89M Sell
48,700
-4,700
-9% -$749K 0.03% 513
2024
Q2
$7.8M Buy
53,400
+33,500
+168% +$4.98M 0.04% 476
2024
Q1
$3.15M Sell
19,900
-141,200
-88% -$22.5M 0.02% 809
2023
Q4
$25.3M Buy
161,100
+97,100
+152% +$14.9M 0.2% 79
2023
Q3
$9.97M Buy
64,000
+44,500
+228% +$7.34M 0.1% 237
2023
Q2
$3.23M Sell
19,500
-28,100
-59% -$4.54M 0.04% 644
2023
Q1
$7.38M Buy
+47,600
New +$7.69M 0.11% 219
2022
Q4
Sell
-6,500
Closed -$1.06M 2619
2022
Q3
$1.06M Buy
6,500
+500
+8% +$84.6K 0.02% 868
2022
Q2
$1.07M Buy
6,000
+2,600
+76% +$463K 0.03% 845
2022
Q1
$602K Sell
3,400
-11,800
-78% -$2.01M 0.01% 1165
2021
Q4
$2.6M Sell
15,200
-240,700
-94% -$39.4M 0.04% 517
2021
Q3
$41.3M Buy
+255,900
New +$43.7M 0.67% 13

Other funds holding JNJ

Paul Tudor Jones's JNJ Position: Q1 2025 in Review

Paul Tudor Jones sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 33,931 shares — an estimated $5.31M sold.

Paul Tudor Jones first reported a position in JNJ in Q2 2013 and held it in 34 quarters. The position peaked at $33.5M in Q1 2023. 4,153 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Paul Tudor Jones reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
  • Paul Tudor Jones sold 33,931 Johnson & Johnson shares in Q1 2025, an estimated $5.31M.
  • Paul Tudor Jones first reported a position in Johnson & Johnson in Q2 2013 and held it in 34 quarters.
  • Paul Tudor Jones's Johnson & Johnson position peaked at $33.5M in Q1 2023.
  • 4,153 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.